Trulieve Cannabis Corp. - Subordinate Voting Shares, no par value (TRLV)

Q: What does CUSIP 89788C104 represent in this 13F holders report?

CUSIP 89788C104 is the security identifier for TRLV - Trulieve Cannabis Corp. - Subordinate Voting Shares, no par value used to aggregate holder disclosures.

Q: How many institutions held TRLV - Trulieve Cannabis Corp. - Subordinate Voting Shares, no par value in Q2 2021?

8 institutional investors reported TRLV - Trulieve Cannabis Corp. - Subordinate Voting Shares, no par value for Q2 2021. Use the holders table for investor-level position and value details.

CUSIP: 89788C104

Q2 2021 13F Holders as of 30 Jun 2021

Security type / class: Equity / Subordinate Voting Shares, no par value
Total 13F shares: 96,442
Total 13F value: $3,618,998
Share change: +4,962
SEC-reported price per share: $37.62
Number of holders: 8
Value change: +$35,205
Number of buys: 3
Number of sells: 7
Shares outstanding: 169,986,454

Security key

89788C104

Report period

Q2 2021

Institutions

Top holders

TRLV full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Trulieve Cannabis Corp. SEC filings Trulieve Cannabis Corp. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 89788C104

Newer quarter: Q3 2025

Recent filing periods:

Q3 2026 Q1 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of TRLV - Trulieve Cannabis Corp. - Subordinate Voting Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Telogia Pharm, LLC

Disclosed value leader

ALBERT D MASON INC

Comparable rows

0/14

Latest evidence

09 Apr 2021

3/4/5 13F Highest disclosed value: $1,701,000 14 rows are not safely comparable across share classes. Showing 1-6 of 14 holder rows.

Quick read

ALBERT D MASON INC has the largest disclosed position value at $1.7M.

0 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ALBERT D MASON INC's linked filing trail.

Disclosed position value Top 5

ALBERT D MASON INC $1.7M

ROTHSCHILD INVESTMENT LLC /IL $824K

GOFEN & GLOSSBERG LLC /IL/ $564K

SYMONS CAPITAL MANAGEMENT INC $563K

LYNCH & ASSOCIATES/IN $205K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 14 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Telogia Pharm, LLC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	— 85,918 shares	—	09 Apr 2021
ALBERT D MASON INC	13F Company 13F	— denominator unverified	$1,701,000 37,389 shares	—	31 Mar 2021
ROTHSCHILD INVESTMENT LLC /IL	13F Company 13F	— denominator unverified	$824,000 18,100 shares	—	31 Mar 2021
GOFEN & GLOSSBERG LLC /IL/	13F Company 13F	— denominator unverified	$564,000 12,400 shares	—	31 Mar 2021
SYMONS CAPITAL MANAGEMENT INC	13F Company 13F	— denominator unverified	$563,000 12,383 shares	—	31 Mar 2021
LYNCH & ASSOCIATES/IN	13F Company 13F	— denominator unverified	$205,000 4,500 shares	—	31 Mar 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

96,442

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2021 vs Q1 2026 Across Filers

Q1 2026 holders

Q2 2021 holders

Holder diff

Investor	Q1 2026 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2021 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend